QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $2.73 billion. The enterprise value is $5.15 billion.
| Market Cap | 2.73B |
| Enterprise Value | 5.15B |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 66.85 million shares outstanding. The number of shares has increased by 16.38% in one year.
| Shares Outstanding | 66.85M |
| Shares Change (YoY) | +16.38% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 100.26% |
| Float | 50.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 16.15 |
| PS Ratio | 0.91 |
| Forward PS | 0.95 |
| PB Ratio | 0.55 |
| P/FCF Ratio | 32.33 |
| PEG Ratio | 7.19 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.94, with an EV/FCF ratio of 61.01.
| EV / Earnings | n/a |
| EV / Sales | 1.72 |
| EV / EBITDA | 8.94 |
| EV / EBIT | 43.45 |
| EV / FCF | 61.01 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.57 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 4.49 |
| Debt / FCF | 30.66 |
| Interest Coverage | 0.80 |
Financial Efficiency
Return on equity (ROE) is -0.20%.
| Return on Equity (ROE) | -0.20% |
| Return on Assets (ROA) | -0.10% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $422,225 |
| Profits Per Employee | -$1,423 |
| Employee Count | 7,100 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.73 |
Taxes
| Income Tax | -19.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.92% in the last 52 weeks. The beta is 0.12, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (1Y) | 0.12 |
| 52-Week Price Change | -55.92% |
| 50-Day Moving Average | 45.12 |
| 200-Day Moving Average | 65.91 |
| Relative Strength Index (RSI) | 39.48 |
| Average Volume (30 Days) | 1,139,848 |
Short Selling Information
The latest short interest is 2.25 million, so 3.37% of the outstanding shares have been sold short.
| Short Interest | 2.25M |
| Short Previous Month | 2.44M |
| Short % of Shares Out | 3.37% |
| Short % of Float | 4.44% |
| Short Ratio (days to cover) | 2.57 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $3.00 billion and -$10.10 million in losses. Loss per share was -$0.15.
| Revenue | 3.00B |
| Gross Profit | 1.49B |
| Operating Income | 139.10M |
| Pretax Income | -29.10M |
| Net Income | -10.10M |
| EBITDA | 575.70M |
| EBIT | 118.50M |
| Loss Per Share | -$0.15 |
Balance Sheet
The company has $167.30 million in cash and $2.59 billion in debt, giving a net cash position of -$2.42 billion or -$36.20 per share.
| Cash & Cash Equivalents | 167.30M |
| Total Debt | 2.59B |
| Net Cash | -2.42B |
| Net Cash Per Share | -$36.20 |
| Equity / Book Value | 5.01B |
| Book Value Per Share | 74.88 |
| Working Capital | 476.70M |
Cash Flow
In the last 12 months, operating cash flow was $280.20 million and capital expenditures -$195.80 million, giving a free cash flow of $84.40 million.
| Operating Cash Flow | 280.20M |
| Capital Expenditures | -195.80M |
| Free Cash Flow | 84.40M |
| FCF Per Share | $1.26 |
Margins
Gross margin is 49.85%, with operating and profit margins of 4.64% and -0.34%.
| Gross Margin | 49.85% |
| Operating Margin | 4.64% |
| Pretax Margin | -0.97% |
| Profit Margin | -0.34% |
| EBITDA Margin | 19.20% |
| EBIT Margin | 3.95% |
| FCF Margin | 2.82% |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.38% |
| Shareholder Yield | -16.38% |
| Earnings Yield | -0.37% |
| FCF Yield | 3.09% |
Analyst Forecast
The average price target for QuidelOrtho is $61.60, which is 50.91% higher than the current price. The consensus rating is "Hold".
| Price Target | $61.60 |
| Price Target Difference | 50.91% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 1.03% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 1.28 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 4 |